Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
08/02/2006 | EP1368413A4 Two-layer imageable element comprising thermally reversible polymers |
08/02/2006 | EP1295514B1 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
08/02/2006 | EP1274692B1 Quinazoline compounds |
08/02/2006 | EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both |
08/02/2006 | EP1072576B1 Fluorinating agent, process for producing the same, and use thereof |
08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
08/02/2006 | CN1812979A Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
08/02/2006 | CN1812975A Process of making di-aryl urea compounds |
08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
08/02/2006 | CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
08/02/2006 | CN1812964A Heterocyclic methyl sulfone derivative |
08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
08/02/2006 | CN1812717A Triazolopyrimidines |
08/02/2006 | CN1810806A Prepn process and intermediate for voriconazole |
08/02/2006 | CN1810802A 3-substituted-4-pyrimidone derivatives |
08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
08/02/2006 | CN1267412C CCR-3 receptor antagonists V |
08/01/2006 | US7084272 formylation and methylation of a 1-(6-substituted pyrimidin-4-yloxy)-2-(2-alkoxy-2-lithiooxyvinyl)benzene |
08/01/2006 | US7084222 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst |
08/01/2006 | US7084163 Applying to plants |
08/01/2006 | US7084158 Substituted propargylamines |
08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
08/01/2006 | US7084144 Sulfonyl group containing compounds and their use for the treatment of erectile dysfunction |
08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
08/01/2006 | US7083832 Combining one or more chiral nonracemic compounds with one or more liquid crystal compounds which have one or more tail groups that are partially fluorinated or that contains one or more silicon atoms |
08/01/2006 | CA2252958C Fungicide salts |
08/01/2006 | CA2208900C Process for preparing 2-pyrimidinecarboxylates |
08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
08/01/2006 | CA2176720C Novel enzyme inhibitors, their synthesis, and methods for use |
08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
07/27/2006 | WO2006076845A1 Process for producing rosuvastatin calcium, intermediate for the preparation of the same and process for producing the intermediate |
07/27/2006 | WO2005061466A9 Novel phenylalanine derivative |
07/27/2006 | US20060167254 Spiro 2,4-pyrimidinediamine compounds and their uses |
07/27/2006 | US20060167253 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril |
07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
07/27/2006 | US20060167105 CCR-3 receptor antagonists |
07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
07/27/2006 | US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor |
07/27/2006 | US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease |
07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
07/27/2006 | US20060166943 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
07/27/2006 | DE4238377B4 Flüssigkristallines Medium Liquid-crystalline medium |
07/27/2006 | CA2593166A1 Mitotic kinesin inhibitors |
07/26/2006 | EP1683789A1 Substituted arylsulfonyl(thio)ureas as herbicides |
07/26/2006 | EP1682536A1 Process for the manufacture of the calcium salt of rosuvastatin (e)-7-'4-(4-fluorophenyl)-6-isopropyl-2-'methyl(methylsulfonyl)amino ! pyrimidin-5-yl!(3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
07/26/2006 | EP1682520A1 Amide derivatives |
07/26/2006 | EP1682508A1 Phenyl derivatives as ppar agonists |
07/26/2006 | EP1682507A1 Benzannelated compounds as ppar activators |
07/26/2006 | EP1682494A1 Aralkyl amines as cannabinoid receptor modulators |
07/26/2006 | EP1682150A2 Compositions and methods for inducing cell dedifferentiation |
07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
07/26/2006 | EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient |
07/26/2006 | EP0801527B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
07/26/2006 | EP0655061B2 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric |
07/26/2006 | CN1809571A Fungicidal triazolopyrimidines. |
07/26/2006 | CN1809569A Pyrimido compounds |
07/26/2006 | CN1809563A Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
07/26/2006 | CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
07/26/2006 | CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents |
07/26/2006 | CN1809357A Small molecule Toll-like receptor (TLR) antagonists |
07/26/2006 | CN1807418A Rosuvastatin calcium synthesis method |
07/26/2006 | CN1807417A Novel waterless crystallization-free rosuvastatin calcium |
07/26/2006 | CN1266133C Process for preparing acetyl substituted nitrogen-containing heterocyclic compound |
07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
07/26/2006 | CN1266098C Substituted dicyclohexylalkyl diphenyl derivative with good low-temperature, mutual solubility, its preparation and application |
07/25/2006 | US7081524 O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
07/25/2006 | US7081461 Quinazoline compounds and pharmaceutical compositions containing them |
07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
07/25/2006 | CA2182105C Chloropyrimide intermediates |
07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
07/20/2006 | WO2006059234A3 Bicyclic amides as kinase inhibitors |
07/20/2006 | US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use |
07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
07/20/2006 | US20060160802 Antibiotics; e.g N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-trifluoromethyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide; N-Hydroxy-N-{cis-4-methyl-1-[N'-(4-methyl-pyrimidin-2-yl)-hydrazinocarbonyl]-cyclohexylmethyl}-formamide |
07/20/2006 | US20060160801 Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
07/20/2006 | US20060159956 Fluorene-based derivative and organic electroluminescence device employing the same |
07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
07/20/2006 | DE4327748B4 Cyclopropyl- und Cyclobutyl-Derivate Cyclopropyl and cyclobutyl derivatives |
07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
07/19/2006 | EP1681058A2 Pharmacologically active cns compounds |
07/19/2006 | EP1680408A2 Ccr3 receptor antagonists |
07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
07/19/2006 | EP1368412A4 Imageable element and composition comprising thermally reversible polymers |
07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
07/19/2006 | CN1805964A 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
07/19/2006 | CN1805937A N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor. |
07/19/2006 | CN1805748A 2-aminopyrimidine derivatives as RAF kinase inhibitors |
07/19/2006 | CN1803778A Method for preparing 2,4,6-trichloro pyrimidine |
07/19/2006 | CN1803777A Chemical synthesis method of pyrimidine thioketone |
07/19/2006 | CN1264824C Quinazoline derivatives |
07/19/2006 | CN1264823C Process for preparing retroviral protease inhibitors and its intermediates |